Benjamin F. Edwards & Company’s abrdn Life Sciences Investors HQL Stock Holding History

Benjamin F. Edwards & Company’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-800	Closed	-$14K	–	1709
2020 Q2	$14K	Hold	800	–	–	﹤0.01%	1204
2020 Q1	$12K	Hold	800	–	–	﹤0.01%	1206
2019 Q4	$14K	Hold	800	–	–	﹤0.01%	1327
2019 Q3	$12K	Hold	800	–	–	﹤0.01%	1343
2019 Q2	$13K	Buy	+800	New	+$13.2K	﹤0.01%	1330

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Benjamin F. Edwards & Company's HQL Position: Q3 2020 in Review

Benjamin F. Edwards & Company sold out of abrdn Life Sciences Investors (HQL) in Q3 2020, closing a stake of 800 shares — an estimated $14K sold.

Benjamin F. Edwards & Company first reported a position in HQL in Q2 2019 and held it in 5 quarters. The position peaked at $14K in Q2 2020. 62 funds tracked by Wall St. Rank hold HQL as of Q3 2020.

Benjamin F. Edwards & Company reported no remaining abrdn Life Sciences Investors position as of Q3 2020 after selling out during the quarter.
Benjamin F. Edwards & Company sold 800 abrdn Life Sciences Investors shares in Q3 2020, an estimated $14K.
Benjamin F. Edwards & Company first reported a position in abrdn Life Sciences Investors in Q2 2019 and held it in 5 quarters.
Benjamin F. Edwards & Company's abrdn Life Sciences Investors position peaked at $14K in Q2 2020.
62 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2020, filed 13 Nov 2020.